New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2013
05:55 EDTSHPG, SHPG, SHPG, SHPG, SHPG, SQNM, SQNM, SQNM, SQNM, SQNM, RHHBY, RHHBY, RHHBY, RHHBY, RHHBY, PFE, PFE, PFE, PFE, PFE, PKI, PKI, PKI, PKI, PKI, LMNX, LMNX, LMNX, LMNX, LMNX, ILMN, ILMN, ILMN, ILMN, ILMN, HOLX, HOLX, HOLX, HOLX, HOLX, FLDM, FLDM, FLDM, FLDM, FLDM, GOLD, GOLD, GOLD, GOLD, GOLD, ATHN, ATHN, ATHN, ATHN, ATHN, ALXN, ALXN, ALXN, ALXN, ALXN, AFFY, AFFY, AFFY, AFFY, AFFY, A, A, A, A, AAmerican College of Medical Genetics & Genomics to hold annual meeting
ACMG Annual Clinical Genetics Meeting 2013 is being held in Phoenix, Arizona on March 19-23.
News For A;AFFY;ALXN;ATHN;GOLD;FLDM;HOLX;ILMN;LMNX;PKI;PFE;RHHBY;SQNM;SHPG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
January 26, 2015
05:15 EDTRHHBYRoche receives FDA clearance for next generation cobas MRSA/SA test
Subscribe for More Information
January 25, 2015
12:30 EDTSHPGShire comments on press release from NPS Pharma on Natpara approval
Subscribe for More Information
January 23, 2015
16:08 EDTPFETeva volatility elevated, Pfizer approached late last year, Bloomberg says
Teva (TEVA) overall option implied volatility of 25 compares to its 26-week average of 23 according to Track Data, suggesting large price movement into Pfizer (PFE) approach late last year, Bloomberg says.
16:04 EDTPFETeva rebuffed Pfizer approach late last year, Bloomberg says
Subscribe for More Information
15:46 EDTLMNX, HOLX, ILMN, SQNM, FLDMPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
08:17 EDTRHHBYRoche management to meet with JPMorgan
Meeting to be held in New York on January 29 hosted by JPMorgan.
January 22, 2015
11:23 EDTPFEPfizer says CHMP adopted positive opinion on Prevenar 13 expansion
Subscribe for More Information
07:04 EDTSQNMSequenom and Cypher Genomics sign prenatal test development agreement
Subscribe for More Information
05:27 EDTSHPGShire reports positive response from European DCP for Elvanse Adult
Subscribe for More Information
January 21, 2015
12:30 EDTPFEGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
10:24 EDTILMNIllumina pulls back following State of the Union address
Shares of Illumina (ILMN) rose yesterday after a biotech industry website reported that President Obama might unveil a major new genomics project during his State of the Union address last night. That speculation was backed as a possibility by an analyst at Wells Fargo ahead of last night's address. In the speech, President Obama unveiled what he called his Precision Medicine Initiative, which relies on genomics to "deliver(s) the right treatment at the right time." Obama spent far more time, however, discussing economic growth and foreign relations than healthcare. Illumina shares are down 3% to $190.64 in early trading today.
09:02 EDTRHHBYRoche's Ventana seeks FDA premarket approval for ALK IHC lung cancer assay
Roche Group member Ventana Medical Systems announced its FDA submission for premarket approval of the Ventana ALK CDx Assay. The companion diagnostic immunohistochemistry test is designed to identify ALK1-positive lung cancer patients that may benefit from treatment with targeted therapy that inhibits the ALK gene. This submission was the fourth and final module and application required by the FDA's PMA process.
January 20, 2015
14:06 EDTSHPGCitizens, Keysight identified as long positions by Einhorn
Subscribe for More Information
13:45 EDTILMN, SQNMIllumina rises as genomics project seen being announced in State of the Union
Subscribe for More Information
11:24 EDTILMNIllumina could see headline boost from U.S. genomics project, says Wells Fargo
After biotech industry publication BioCentury said Friday that the president may announce a new genomics project to sequence up to one million human genomes as part of his State of the Union speech tonight, Wells Fargo said that it believes such an announcement could be a headline catalyst for Illumina since it would mean the U.S. needs additional sequencing capacity. However, such a project would be long-term in nature, Wells Fargo cautioned, adding that such a plan would more likely support existing Illumina growth assumptions than push those forecasts up. Shares of Illumina are up 6% to $194.85 in morning trading ahead of tonight's speech by the president.
08:53 EDTHOLXHologic upgraded to Outperform from Market Perform at William Blair
Subscribe for More Information
08:30 EDTHOLXHologic upgraded to Outperform from Market Perform at William Blair
Subscribe for More Information
08:10 EDTSHPGShire price target raised to $247 from $228 at Jefferies
Subscribe for More Information
07:53 EDTFLDMFluidigm upgraded to Outperform at Cowen
Subscribe for More Information
06:36 EDTFLDMFluidigm upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use